야간 빈뇨 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 적응증별, 약물 유형별, 유통 채널별, 지역별
Nocturia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
상품코드:1454882
리서치사:Fairfield Market Research
발행일:2024년 03월
페이지 정보:영문 192 Pages
라이선스 & 가격 (부가세 별도)
한글목차
이 보고서는 세계 야간 빈뇨 시장에 대해 조사했으며, 시장 개요와 함께 적응증별/약품 유형별/유통 채널별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter의 Five Forces 분석
COVID-19의 영향 분석
우크라이나·러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 야간 빈뇨 시장 전망, 2018년-2031년
세계의 야간 빈뇨 시장 전망, 적응증별, 금액(10억 달러), 2018년-2031년
세계의 야간 빈뇨 시장 전망, 약제 유형별, 금액(10억 달러), 2018년-2031년
세계의 야간 빈뇨 시장 전망, 유통 채널별, 금액(10억 달러), 2018년-2031년
세계의 야간 빈뇨 시장 전망, 지역별, 금액(10억 달러), 2018년-2031년
제4장 북미의 야간 빈뇨 시장 전망, 2018년-2031년
제5장 유럽의 야간 빈뇨 시장 전망, 2018년-2031년
제6장 아시아태평양의 야간 빈뇨 시장 전망, 2018년-2031년
제7장 라틴아메리카의 야간 빈뇨 시장 전망, 2018년-2031년
제8장 중동 및 아프리카의 야간 빈뇨 시장 전망, 2018년-2031년
제9장 경쟁 구도
적응증 vs. 유통 채널 히트맵
제조업체와 유통 채널 히트맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 개요
Allergan, Inc.
Urigen Pharmaceuticals
Ferring Pharmaceuticals
Glenmark Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
AA Pharma Inc.
Avadel Pharmaceuticals plc
제10장 부록
LSH
영문 목차
영문목차
Fairfield Market Research a leading provider of market research reports, has released a comprehensive analysis of the global nocturia market spanning the period 2024-2031. The report aims to provide industry stakeholders with valuable updates on market trends and opportunities within the global landscape.
Rising Disease Prevalence Fuels Market Growth
The primary objective of the report is to shed light on developments in the Nocturia market that are reshaping businesses worldwide. Factors such as the increasing prevalence of cancer, diabetes, and cardiovascular diseases on a global scale have significantly contributed to the market's revenue growth. With a substantial portion of the population affected by these ailments, there is a growing demand for treatments targeting nocturia symptoms.
Driving Forces and Market Opportunities
The report highlights the factors expected to drive revenue growth in the global nocturia market, including greater access to manufacturing infrastructure, increased utilization of Contract Manufacturing Organizations (CMOs), and advancements in drug delivery systems. However, it also acknowledges challenges such as high operational costs and competition from low-cost manufacturers, which could potentially hinder market expansion.
Market Segmentation and Forecast
Fairfield Market Research analysis explores the global nocturia market performance, categorizing revenue contributions by different drug types. Among them, Desmopressin is anticipated to maintain its market leadership, with a projected growth rate throughout the forecast period. The Desmopressin segment's valuation, recorded in the past, is expected to see significant growth by the end of the assessment period.
Competitive Analysis
In the competitive assessment section, the report provides a detailed analysis of key market players, offering insights into their long-term and short-term strategies. Major manufacturing companies such as Allergan, Inc., Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., AA Pharma Inc., and Avadel Pharmaceuticals plc are profiled, highlighting their product offerings and recent developments in the nocturia market.
Emphasis on Decision-Making Insights
The report includes impact analyses of key trends, drivers, challenges, and opportunities to equip clients with actionable information for strategic decision-making. Additionally, it features a competitive landscape with a dashboard view, enabling stakeholders to discern key differentiators among competitor firms.
Global Nocturia Market: Segmentation
Market segmentation by indication
Mixed nocturia
Low nocturnal bladder capacity
Nocturnal polyuria
Global polyuria
Market segmentation by drug type
Anticholinergic drugs
Desmopressin
Antibiotics
Antispasmodic
Others
Market segmentation by distribution channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Market Segmentation by region
North America
Latin America
Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa
Table of Contents
1. Executive Summary
1.1. Global Nocturia Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Nocturia Market Outlook, 2018 - 2031
3.1. Global Nocturia Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Mixed nocturia
3.1.1.2. Low nocturnal bladder capacity
3.1.1.3. Nocturnal polyuria
3.1.1.4. Global polyuria
3.2. Global Nocturia Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Anticholinergic drugs
3.2.1.2. Desmopressin
3.2.1.3. Antispasmodic
3.2.1.4. Others
3.3. Global Nocturia Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. Drug Stores
3.3.1.4. Online Pharmacies
3.4. Global Nocturia Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Nocturia Market Outlook, 2018 - 2031
4.1. North America Nocturia Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Mixed nocturia
4.1.1.2. Low nocturnal bladder capacity
4.1.1.3. Nocturnal polyuria
4.1.1.4. Global polyuria
4.2. North America Nocturia Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Anticholinergic drugs
4.2.1.2. Desmopressin
4.2.1.3. Antispasmodic
4.2.1.4. Others
4.3. North America Nocturia Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. Drug Stores
4.3.1.4. Online Pharmacies
4.4. North America Nocturia Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Nocturia Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Nocturia Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Nocturia Market Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Nocturia Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Nocturia Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Nocturia Market Distribution Channel, Value (US$ Bn), 2018 - 2031
